Epidemiology and survival outcomes in stages II and III cutaneous melanoma: a systematic review

ανά Miller, Rachael, Walker, Sophie, Shui, Irene, Brandtmüller, Agnes, Cadwell, Kevin, Scherrer, Emilie
Τόπος έκδοσης Melanoma Manag (2020)

An indirect treatment comparison of the efficacy of pembrolizumab versus competing regimens for the adjuvant treatment of stage III melanoma

ανά Lorenzi, Maria, Arndorfer, Stella, Aguiar-Ibañez, Raquel, Scherrer, Emilie, Liu, Frank Xiaoqing, Krepler, Clemens
Τόπος έκδοσης J Drug Assess (2019)

An observational study of drug utilization and associated outcomes among adult patients diagnosed with BRAF‐mutant advanced melanoma treated with first‐line anti‐PD‐1 monotherapies...

ανά Cowey, Charles L., Boyd, Marley, Aguilar, Kathleen M., Beeks, April, Krepler, Clemens, Scherrer, Emilie
Τόπος έκδοσης Cancer Med (2020)

Pembrolizumab Utilization and Clinical Outcomes Among Patients With Advanced Melanoma in the US Community Oncology Setting: An Updated Analysis

ανά Cowey, Charles Lance, Scherrer, Emilie, Boyd, Marley, Aguilar, Kathleen M., Beeks, April, Krepler, Clemens
Τόπος έκδοσης J Immunother (2021)

Cost-Effectiveness of Pembrolizumab for the Adjuvant Treatment of Melanoma Patients with Lymph Node Involvement Who Have Undergone Complete Resection in Argentina

ανά Wurcel, Victoria, Scherrer, Emilie, Aguiar-Ibanez, Raquel, Altuna, Juan Ignacio, Carabajal, Fernando, Jain, Shrishti, Baluni, Gargi
Τόπος έκδοσης Oncol Ther (2021)

An Economic Evaluation of Pembrolizumab Versus Other Adjuvant Treatment Strategies for Resected High-Risk Stage III Melanoma in the USA

ανά Bensimon, Arielle G., Zhou, Zheng-Yi, Jenkins, Madeline, Song, Yan, Gao, Wei, Signorovitch, James, Krepler, Clemens, Scherrer, Emilie, Wang, Jingshu, Aguiar-Ibáñez, Raquel
Τόπος έκδοσης Clin Drug Investig (2020)